Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to 145.09%.

  • Rapid Micro Biosystems' EBIT Margin rose 132400.0% to 145.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 148.77%, marking a year-over-year increase of 494600.0%. This contributed to the annual value of 177.96% for FY2024, which is 732200.0% up from last year.
  • According to the latest figures from Q3 2025, Rapid Micro Biosystems' EBIT Margin is 145.09%, which was up 132400.0% from 167.28% recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' EBIT Margin ranged from a high of 124.47% in Q4 2024 and a low of 394.6% during Q4 2022
  • Over the past 5 years, Rapid Micro Biosystems' median EBIT Margin value was 202.15% (recorded in 2024), while the average stood at 238.94%.
  • In the last 5 years, Rapid Micro Biosystems' EBIT Margin plummeted by -1874200bps in 2022 and then soared by 2022700bps in 2023.
  • Quarter analysis of 5 years shows Rapid Micro Biosystems' EBIT Margin stood at 279.49% in 2021, then tumbled by -41bps to 394.6% in 2022, then surged by 51bps to 192.33% in 2023, then skyrocketed by 35bps to 124.47% in 2024, then dropped by -17bps to 145.09% in 2025.
  • Its EBIT Margin stands at 145.09% for Q3 2025, versus 167.28% for Q2 2025 and 161.85% for Q1 2025.